21 DEC 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Health Promotion Partnership with Gunma Prefecture
20 DEC 2016 Pharmaceuticals Akebia Therapeutics and Otsuka Pharmaceutical Announce Collaboration to Develop and Commercialize Vadadustat in the U.S.
20 DEC 2016 Nutraceuticals JSC High Performance Center Total Conditioning Research Project Joint research aims to promote sports medicine and science and boost international competitiveness (PDF: 190.3 KB)
15 DEC 2016 Pharmaceuticals Otsuka Signs Japan-Exclusive License Agreement with Takara Bio for the Investigational Cancer Treatment HF10, an Oncolytic Virus
5 DEC 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Comprehensive Cooperative Partnership with Nara Prefecture
1 DEC 2016 Pharmaceuticals FDA Accepts For Review A Supplemental New Drug Application To Expand Labeling Of Abilify Maintena® (aripiprazole) For The Treatment Of Bipolar I Disorder
24 NOV 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Cooperative Agreements with Hokkaido Government Entities - Partnership Agreement for Promotion of Hokkaido Residents' Health Initiatives - - Cooperative Accord for Children's Education and Sports Promotion -
21 NOV 2016 Corporate Otsuka Pharmaceutical Cooperates with Community Health Promotion Efforts Tokushima Itano Factory Sponsors Asan Walking Festival in Itano
18 NOV 2016 Pharmaceuticals ICLUSIG® Tablets 15 mg Now Available in Japan for Patients with Chronic Myeloid Leukemia and Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
10 NOV 2016 Nutraceuticals Relationship between PMS/PMDD and production status of soy isoflavone metabolite equol Presentation to the Japan Society for Menopause and Women's Health
1 NOV 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Comprehensive Partnership with Hyogo Prefecture
31 OCT 2016 Nutraceuticals Heatstroke Prevention Communication Project Hitosuzumi Awards 2016 Otsuka Pharmaceutical Named "Best Communicator" for Third Consecutive Year Proactive Efforts to Raise Awareness Also Recognized with "Top Runner Award"
19 OCT 2016 Pharmaceuticals Positive Phase III Clinical Trial Results for Ribociclib (LEE011), an Investigational Compound for Advanced Breast Cancer in Development by Major Pharmaceutical Company under a Research Collaboration with Otsuka's Subsidiary Astex Pharmaceuticals
18 OCT 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Disaster Support Agreement with Fukui Prefecture
28 SEP 2016 Pharmaceuticals Otsuka Receives Approval in Japan for Mikeluna® Combination Ophthalmic Solution, a New Treatment for Glaucoma and Ocular Hypertension
28 SEP 2016 Pharmaceuticals Antipsychotic ABILIFY Gains Approval in Japan for the Additional Indication of Irritability Associated with Pediatric Autism Spectrum Disorder
28 SEP 2016 Pharmaceuticals ICLUSIG® Tablets 15 mg Approved in Japan for Patients with Chronic Myeloid Leukemia and Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
26 SEP 2016 Pharmaceuticals U.S. FDA Approves Labeling Update of REXULTI®(brexpiprazole) for Maintenance Treatment of Schizophrenia in Patients in the U.S.
26 SEP 2016 Pharmaceuticals Headline conclusions from the phase III study of idalopirdine (Lu AE58054) for cognitive symptoms associated with Alzheimer's disease
15 SEP 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Health Promotion Partnership with Yamanashi Prefecture
7 SEP 2016 Pharmaceuticals Otsuka and NEC agree to develop a smart medicine container to assist patients in taking daily anti-stroke medication at the appropriate time
7 SEP 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Partnership Agreement with Yamagata Prefecture, Aiming to Achieve Japan's Top Healthy Life Expectancy
2 SEP 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Comprehensive Cooperative Agreement with Kanagawa Prefecture
1 SEP 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Comprehensive Health Promotion Partnership with Kumamoto Prefecture
1 SEP 2016 Pharmaceuticals RIKEN CDB-Otsuka Pharmaceutical Collaboration Center launches (PDF: 90.0 KB)
31 AUG 2016 Nutraceuticals Otsuka Pharmaceutical Enters Into Health Promotion Partnership with Toyama Prefecture
16 AUG 2016 Corporate Otsuka Pharmaceutical Participates in Summer Events in Tokushima Exciting Summer in WAJIKI, Tokushima Awa Odori, Oronamin C Drink Presents Awa Odori Sound Festival
9 AUG 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Health Promotion Partnership with Miyagi Prefecture
5 AUG 2016 Corporate Notice of Completion of Transfer of Shares Held by Otsuka Pharmaceutical Co., Ltd.
13 JUL 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Comprehensive Partnership with Shizuoka Prefecture
8 JUL 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Health Promotion Partnership with Gifu Prefecture
5 JUL 2016 Pharmaceuticals ORALTAG™(iohexol), a New Oral Contrast Agent for Abdominal CT Scans, Launched in U.S. Developed by Otsuka Subsidiary Interpharma Praha
29 JUN 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Comprehensive Partnership with Miyazaki Prefecture
27 JUN 2016 Corporate Otsuka Pharmaceutical Donates Funds for a Sub Rural Health Center in Myanmar For the stable provision of maternal and child health services
14 JUN 2016 Pharmaceuticals Announcement of Termination of Co-Development and Co-Commercialization Agreements with Acucela, Inc.
13 JUN 2016 Corporate Otsuka Pharmaceutical and IBM Japan to Set Up Joint Venture for Digital Health Solutions in Central Nervous System Field
7 JUN 2016 Pharmaceuticals VONOSAP® pack 400, VONOSAP® pack 800 and VONOPION®pack (triple-drug blister packs containing TAKECAB® tablet) Now Available for Helicobacter pylori* Eradication in Japan
30 MAY 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Health Promotion Partnership Agreement with Akita Prefecture
26 MAY 2016 Nutraceuticals Thirst-quenching support for optimum day-to-day condition Introducing New POCARI SWEAT Ion Water Powder (to make 750ml)
25 MAY 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Health Promotion Partnership with Fukushima Prefecture
25 MAY 2016 Pharmaceuticals "Neupro® Patch", a Dopaminergic, Anti-Parkinsonian Drug,Will Become Available in Japan in an Additional New Dosage, "Neupro Patch 18 mg"
24 MAY 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Health Promotion Partnership with Nagasaki Prefecture
19 MAY 2016 Corporate Otsuka Pharmaceutical to Support Japan's COOL CHOICE Movement Cooperation in Public Awareness Campaigns to Encourage Wise Decisions to Counteract Global Warming
13 MAY 2016 Nutraceuticals Otsuka Pharmaceutical Enters Into Comprehensive Partnership Agreement with Osaka Prefecture
9 MAY 2016 Nutraceuticals Introducing Three New Flavors of Calorie Mate Jelly Focusing on the Need for a Nutritionally Balanced Jelly Beverage Option
27 APR 2016 Pharmaceuticals FDA Issues Complete Response Letter For Digital Medicine New Drug Application
26 APR 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Health Promotion Partnership with Kagoshima Prefecture
22 APR 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Comprehensive Partnership with Mie Prefecture
21 APR 2016 Pharmaceuticals Otsuka receives two commendations by the Japanese Government for the development of an anti-tuberculosis agent and an aquaretic/ADPKD treatment
20 APR 2016 Pharmaceuticals Otsuka's U.S. Subsidiary Astex Pharmaceuticals Enters Clinical Trial Collaboration to Explore the Potential of Combining Guadecitabine (SGI-110) with Atezolizumab in the Treatment of Acute Myeloid Leukemia
12 APR 2016 Nutraceuticals Otsuka Pharmaceutical Launches "POCARI SWEAT & TOKYO Project" in Cooperation with Tokyo Metropolitan Government
4 APR 2016 Nutraceuticals New POCARI SWEAT Jelly for "Edible Hydration" First new form of POCARI SWEAT since initial launch 36 years ago
1 APR 2016 Nutraceuticals Thirst-quenching beverage aims to help women maintain optimum day-to-day condition Renewed Version of POCARI SWEAT Ion Water
31 MAR 2016 Nutraceuticals Otsuka Pharmaceutical Signs Health Promotion Support Agreement with Hyogo Prefecture
30 MAR 2016 Nutraceuticals Otsuka Pharmaceutical Enters Into Comprehensive Partnership with Hiroshima Prefecture
28 MAR 2016 Nutraceuticals Otsuka Pharmaceutical Enters into Disaster Relief Supply Agreement with Ishikawa Prefecture
16 MAR 2016 Nutraceuticals Otsuka Pharmaceutical Enters Into Health Promotion Partnership with Okayama Prefecture
15 MAR 2016 Nutraceuticals New casual soy bar with the pleasant crunchy texture of puffed soy "SOYJOY Crispy" Debuts in Three Flavors
11 MAR 2016 Nutraceuticals Otsuka Pharmaceutical Supports 37,000 Runners with Nutritional and Rehydration Products and Cadre of Blue Volunteers at Tokyo Marathon 2016
8 MAR 2016 Corporate Otsuka Pharmaceutical Co., Ltd. Appoints Board Members and Statutory Auditors (PDF: 40.6 KB)
2 MAR 2016 Pharmaceuticals ABILIFY for Extended Release Injectable Suspension, Used to treat Schizophrenia, Has Received Approval in Japan for Administration at Deltoid Muscle Site
29 FEB 2016 Pharmaceuticals Anti-epileptic Drug E Keppra® (generic name: levetiracetam) Obtains Additional Indication of Adjunctive Therapy for Generalized Tonic-Clonic Seizures in Japan
26 FEB 2016 Pharmaceuticals Takeda Obtains NDA Approval for Helicobacter pylori* Eradication triple-drug Blister Packs Containing TAKECAB tablet, "VONOSAP® pack 400", "VONOSAP® pack 800" and "VONOPION® pack" in Japan
25 FEB 2016 Pharmaceuticals Otsuka Announces Worldwide Access Plan for Delamanid with Stop TB Partnership's Global Drug Facility
22 FEB 2016 Nutraceuticals Otsuka Pharmaceutical Enters Partnership Agreement with Aomori Prefecture on Health Literacy* Enhancement
19 FEB 2016 Nutraceuticals Otsuka Pharmaceutical to Support Japan Anti-Doping Agency's Official Sports Pharmacist Certification System
19 FEB 2016 Nutraceuticals Otsuka Pharmaceutical Enters Into Comprehensive Health Promotion Partnership with Tokushima Prefecture
9 FEB 2016 Pharmaceuticals Otsuka and Medimetriks Sign Licensing Agreement for Development and Commercialization of OPA-15406 in the U.S. for Atopic Dermatitis
29 JAN 2016 Pharmaceuticals Otsuka's Subsidiary Avanir Pharmaceuticals Announces U.S. FDA Approval of ONZETRA™Xsail™ for the Acute Treatment of Migraine in Adults
26 JAN 2016 Nutraceuticals Otsuka Pharmaceutical Forms Joint Venture Company for Functional Food and Beverages in the Philippines
13 JAN 2016 Nutraceuticals Otsuka Pharmaceutical Enters Into Comprehensive Health Promotion Partnership with Iwate Prefecture
8 JAN 2016 Pharmaceuticals Otsuka and ARIAD Announce New Drug Application for Ponatinib Submitted in Japan for the Treatment of Refractory Leukemia